Shawn Cline Tomasello - 19 Oct 2023 Form 4/A - Amendment Insider Report for Gamida Cell Ltd.

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 19 Oct 2023
Net transaction value: $0
SEC form: 4/A - Amendment
Accepted by SEC: 20 Oct 2023, 16:39:11 UTC
Original report date: 22 Mar 2023
Prior SEC filing: 24 Jul 2023
Next SEC filing: 02 Feb 2024
Source filing: View source filing
Reporting owner signature: /s/ Joshua F. Patterson, Attorney-in-Fact

Key filing fact

Shawn Cline Tomasello filed Form 4/A - Amendment for Gamida Cell Ltd. on 20 Oct 2023.

Key facts

This page summarizes Shawn Cline Tomasello's Form 4/A - Amendment filing for Gamida Cell Ltd..
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 20 Oct 2023, 16:39.

Change

Previous filing in this sequence was filed on 24 Jul 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GMDA transaction Derivative

Share Option (Right to Buy)

Award

Transaction value: $0
Shares: +17,000
Change %
Price: $0.000000
Shares after: 17,000
Date: 19 Oct 2023
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 17,000
Exercise price: $1.32
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The option grant was approved by the Board of Directors of the Issuer on March 20, 2023, subject to shareholder approval. The Issuer's shareholders approved the grant at the annual general meeting of the shareholders on October 19, 2023.

Footnote F2

This option vests in equal quarterly installments over a twelve-month period, with the first such installment vesting on May 8, 2023, subject to the Reporting Person's continuous service through each such vesting date.

SEC remarks

This amendment is being filed solely to correct the transaction date to October 19, 2023 and the expiration date to October 18, 2033.